|Bid||73.85 x 300|
|Ask||73.87 x 200|
|Day's Range||73.62 - 74.27|
|52 Week Range||63.76 - 82.10|
|PE Ratio (TTM)||7.82|
|Dividend & Yield||2.08 (2.80%)|
|1y Target Est||N/A|
The Fed will be overshadowed on Wednesday by the continued parade of corporate earnings coming out this week.
The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Gilead Sciences, Inc.'s revenue is estimated to decline by just over 18% when it reports its Q2 results.